Immunoblot analysis of tissue lysates has revealed significantly reduced LMTK2 levels in mid dementia (Braak stage III-IV) and sever dementia (Braak stage VI) cases in the cortex compared to controls. The gene discussed is LMTK2; the disease is dementia.